Cell line · CVCL_1155
D283 Med
Cancer cell line, Homo sapiens. Medulloblastoma, non-WNT/non-SHH, group 3. 36 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. D283 Med. Cell lines, record CVCL_1155. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1155
On this page
Cell line
As Cellosaurus gives it.
- Name
- D283 Med
- Accession
- CVCL_1155
- RRID
- RRID:CVCL_1155
- Synonyms
- D283 MED, D283-MED, D283_Med, D-283 Med, D-283 Med-C, D-283MED, D283MED, D283Med, D283-Med, D-283, D283, Med 283, H283
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 6Y
- Category
- Cancer cell line
- Diseases
- Medulloblastoma, non-WNT/non-SHH, group 3 (NCIt C129445); Medulloblastoma (ORDO Orphanet_616)
- Derived from
- Ascites (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers36
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| 18β-Glycyrrhetinic Acid Exerts Subgroup-Specific Antitumor Activity and Enhances Radiosensitivity in Medulloblastoma. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Detection of structural DNA variants in medulloblastomas using optical genome mapping. | Acta Neuropathol Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exploring the prognostic molecular mechanisms of medulloblastoma through methylation-transcriptome integration. | SAGE Open Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The dual HDAC/PI3K inhibitor CUDC-907 inhibits the growth and proliferation of MYC-driven Group 3 medulloblastoma. | Cell Death Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Identification and validation of a metabolism-related gene signature for predicting the prognosis of paediatric medulloblastoma. | Sci Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | Mol Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 36
See all 36 papersRelatives0
None in this release.
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-185 | ATCC | |
| CLS | 300330 | CLS | |
| IZSLER | BS TCL 203 | Cellosaurus | |
| KCB | KCB 2010201YJ | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1155
GET https://conductscience.org/api/cell-lines/v1/CVCL_1155/papers?page=2